Alpha Healthcare Acquisition Corp. III has completed its previously announced business combination with Carmell Therapeutics Corporation. Post-combination, Legacy Carmell has become a wholly-owned subsidiary of the new Carmell Therapeutics Corporation and the common stock was listed on the Nasdaq Capital Market under the new trading symbol 'CTCX'.